Reducing AD-Like Pathology in 3xTg-AD Mouse Model by DNA Epitope Vaccine — A Novel Immunotherapeutic Strategy

Nina Movsesyan, Anahit Ghochikyan, Mikayel Mkrtichyan et al. · 2008

Read Reducing AD-Like Pathology in 3xTg-AD Mouse Model by DNA Epitope Vaccine — A Novel Immunotherapeutic Strategy by Nina Movsesyan, Anahit Ghochikyan, Mikayel Mkrtichyan et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0002124.txt.

Description

Nina Movsesyan, Anahit Ghochikyan, Mikayel Mkrtichyan, and co-authors tested a vaccine idea for Alzheimer's disease in a 2008 PLOS ONE paper. They used the 3xTg-AD mouse, a strain bred to develop brain changes much like those seen in the human disease. A safe vaccine for this illness must raise antibodies against the amyloid-beta protein without stirring up harmful T cell attacks on the brain.

The team built a DNA vaccine that presents only small pieces, called epitopes, of the target protein. Their goal was to cut the Alzheimer's-like damage in the mice while avoiding the risky immune response that had blocked earlier vaccine tries. The paper adds one careful route toward immune therapy for the disease.

Catalog record

CREATORNina Movsesyan, Anahit Ghochikyan, Mikayel Mkrtichyan et al.
YEAR2008
COLLECTIONPAPERS
FORMATTXT
FILE SIZE58 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0002124

Browse the full library · About the Tower of Babel